ID   DGKA_HUMAN              Reviewed;         735 AA.
AC   P23743; O75481; O75482; O75483; O95217; Q3ZE25; Q8IZ56; Q8N5Q2;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 3.
DT   10-MAY-2017, entry version 182.
DE   RecName: Full=Diacylglycerol kinase alpha;
DE            Short=DAG kinase alpha;
DE            EC=2.7.1.107;
DE   AltName: Full=80 kDa diacylglycerol kinase;
DE   AltName: Full=Diglyceride kinase alpha;
DE            Short=DGK-alpha;
GN   Name=DGKA; Synonyms=DAGK, DAGK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphocyte;
RX   PubMed=2175712; DOI=10.1016/0014-5793(90)81461-V;
RA   Schaap D., de Widt J., van der Wal J., Vandekerckhove J.,
RA   van Damme J., Gussow D., Ploegh H.L., van Blitterswijk W.J.,
RA   van der Bendl R.L.;
RT   "Purification, cDNA-cloning and expression of human diacylglycerol
RT   kinase.";
RL   FEBS Lett. 275:151-158(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Uterus;
RA   Champagne C.M.E., Maeda H., Takashiba S., van Dyke T.E.;
RT   "Alternative splicing of diacylglycerol kinase alpha expressed in
RT   human neutrophils.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Batista E.L. Jr., Van Dyke T.E.;
RT   "Characterization of a novel DGK alpha transcript generated by
RT   alternative splicing.";
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TYR-538.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL LOCATION.
RX   PubMed=8180475; DOI=10.1007/BF00292343;
RA   Hart T.C., Champagne C., Zhou J., van Dyke T.E.;
RT   "Assignment of the gene for diacylglycerol kinase (DAGK) to human
RT   chromosome 12.";
RL   Mamm. Genome 5:123-124(1994).
RN   [7]
RP   CHROMOSOMAL LOCATION.
RX   PubMed=7959783; DOI=10.1006/geno.1994.1376;
RA   Hart T.C., Zhou J., Champagne C., van Dyke T.E., Rao P.N.,
RA   Pettenati M.J.;
RT   "Assignment of the human diacylglycerol kinase gene (DAGK) to 12q13.3
RT   using fluorescence in situ hybridization analysis.";
RL   Genomics 22:246-247(1994).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-484, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   STRUCTURE BY NMR OF 1-118.
RG   Northeast structural genomics consortium (NESG);
RT   "NMR structure of diacylglycerol kinase alpha, NESGC target HR532.";
RL   Submitted (JAN-2005) to the PDB data bank.
CC   -!- FUNCTION: Upon cell stimulation converts the second messenger
CC       diacylglycerol into phosphatidate, initiating the resynthesis of
CC       phosphatidylinositols and attenuating protein kinase C activity.
CC   -!- CATALYTIC ACTIVITY: ATP + 1,2-diacyl-sn-glycerol = ADP + 1,2-
CC       diacyl-sn-glycerol 3-phosphate.
CC   -!- ENZYME REGULATION: Stimulated by calcium and phosphatidylserine.
CC       Phosphorylated by protein kinase C.
CC   -!- SUBUNIT: Monomer.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P23743-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23743-2; Sequence=VSP_032212, VSP_032213;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=P23743-3; Sequence=VSP_047702, VSP_047703;
CC   -!- TISSUE SPECIFICITY: Lymphocytes and oligodendroglial cells.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X62535; CAA44396.1; -; mRNA.
DR   EMBL; AF064767; AAC34802.1; -; mRNA.
DR   EMBL; AF064768; AAC34803.1; -; mRNA.
DR   EMBL; AF064769; AAC34804.1; -; mRNA.
DR   EMBL; AF064771; AAC34806.1; -; mRNA.
DR   EMBL; AY930112; AAY20994.1; -; mRNA.
DR   EMBL; AC025162; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC023523; AAH23523.1; -; mRNA.
DR   EMBL; BC031870; AAH31870.1; -; mRNA.
DR   CCDS; CCDS8896.1; -. [P23743-1]
DR   PIR; S12969; S12969.
DR   RefSeq; NP_001336.2; NM_001345.4. [P23743-1]
DR   RefSeq; NP_958852.1; NM_201444.2. [P23743-1]
DR   RefSeq; NP_958853.1; NM_201445.1. [P23743-1]
DR   RefSeq; NP_963848.1; NM_201554.1. [P23743-1]
DR   RefSeq; XP_011536293.1; XM_011537991.2. [P23743-1]
DR   RefSeq; XP_011536295.1; XM_011537993.2. [P23743-1]
DR   UniGene; Hs.524488; -.
DR   PDB; 1TUZ; NMR; -; A=1-116.
DR   PDBsum; 1TUZ; -.
DR   ProteinModelPortal; P23743; -.
DR   SMR; P23743; -.
DR   BioGrid; 107976; 4.
DR   IntAct; P23743; 4.
DR   MINT; MINT-8020268; -.
DR   STRING; 9606.ENSP00000328405; -.
DR   DrugBank; DB00163; Vitamin E.
DR   SwissLipids; SLP:000000555; -.
DR   SwissLipids; SLP:000000739; -.
DR   iPTMnet; P23743; -.
DR   PhosphoSitePlus; P23743; -.
DR   BioMuta; DGKA; -.
DR   DMDM; 281185505; -.
DR   EPD; P23743; -.
DR   MaxQB; P23743; -.
DR   PaxDb; P23743; -.
DR   PeptideAtlas; P23743; -.
DR   PRIDE; P23743; -.
DR   DNASU; 1606; -.
DR   Ensembl; ENST00000331886; ENSP00000328405; ENSG00000065357. [P23743-1]
DR   Ensembl; ENST00000394147; ENSP00000377703; ENSG00000065357. [P23743-1]
DR   Ensembl; ENST00000402956; ENSP00000385792; ENSG00000065357. [P23743-3]
DR   Ensembl; ENST00000548549; ENSP00000448565; ENSG00000065357. [P23743-2]
DR   Ensembl; ENST00000551156; ENSP00000450359; ENSG00000065357. [P23743-1]
DR   Ensembl; ENST00000553084; ENSP00000446605; ENSG00000065357. [P23743-2]
DR   GeneID; 1606; -.
DR   KEGG; hsa:1606; -.
DR   UCSC; uc001sij.4; human. [P23743-1]
DR   CTD; 1606; -.
DR   DisGeNET; 1606; -.
DR   GeneCards; DGKA; -.
DR   HGNC; HGNC:2849; DGKA.
DR   HPA; HPA041645; -.
DR   HPA; HPA045462; -.
DR   MIM; 125855; gene.
DR   neXtProt; NX_P23743; -.
DR   OpenTargets; ENSG00000065357; -.
DR   PharmGKB; PA27310; -.
DR   eggNOG; KOG1169; Eukaryota.
DR   eggNOG; ENOG410XQVB; LUCA.
DR   GeneTree; ENSGT00760000119050; -.
DR   HOVERGEN; HBG051345; -.
DR   InParanoid; P23743; -.
DR   KO; K00901; -.
DR   OMA; VGLHCVW; -.
DR   OrthoDB; EOG091G04A5; -.
DR   PhylomeDB; P23743; -.
DR   TreeFam; TF313104; -.
DR   BRENDA; 2.7.1.107; 2681.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   SABIO-RK; P23743; -.
DR   SIGNOR; P23743; -.
DR   ChiTaRS; DGKA; human.
DR   EvolutionaryTrace; P23743; -.
DR   GeneWiki; DGKA; -.
DR   GenomeRNAi; 1606; -.
DR   PRO; PR:P23743; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000065357; -.
DR   CleanEx; HS_DGKA; -.
DR   ExpressionAtlas; P23743; baseline and differential.
DR   Genevisible; P23743; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004143; F:diacylglycerol kinase activity; IDA:BHF-UCL.
DR   GO; GO:0016301; F:kinase activity; IDA:BHF-UCL.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0005543; F:phospholipid binding; IEA:Ensembl.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; IDA:BHF-UCL.
DR   GO; GO:0046486; P:glycerolipid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0046834; P:lipid phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR029477; DAG_kinase_typeI_N.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF14513; DAG_kinase_N; 2.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF111331; SSF111331; 2.
DR   SUPFAM; SSF47473; SSF47473; 3.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Calcium;
KW   Complete proteome; Kinase; Metal-binding; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Repeat; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    735       Diacylglycerol kinase alpha.
FT                                /FTId=PRO_0000218453.
FT   DOMAIN      110    145       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      155    190       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      372    506       DAGKc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   CA_BIND     123    134       1. {ECO:0000305}.
FT   CA_BIND     168    179       2. {ECO:0000305}.
FT   ZN_FING     205    253       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     269    319       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   MOD_RES     484    484       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     117    118       FT -> WS (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_032212.
FT   VAR_SEQ     119    735       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_032213.
FT   VAR_SEQ     237    247       LCKYTVHDQCA -> RPITCVGARRL (in isoform
FT                                3). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_047702.
FT   VAR_SEQ     248    735       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_047703.
FT   VARIANT     538    538       H -> Y (in dbSNP:rs17852990).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031563.
FT   CONFLICT    339    339       L -> P (in Ref. 2; AAC34804).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       V -> L (in Ref. 2; AAC34802).
FT                                {ECO:0000305}.
FT   CONFLICT    385    385       S -> W (in Ref. 2; AAC34802).
FT                                {ECO:0000305}.
FT   CONFLICT    684    684       E -> G (in Ref. 2; AAC34803).
FT                                {ECO:0000305}.
FT   CONFLICT    699    699       G -> V (in Ref. 1; CAA44396).
FT                                {ECO:0000305}.
FT   CONFLICT    715    715       N -> K (in Ref. 2; AAC34803).
FT                                {ECO:0000305}.
FT   HELIX        10     22       {ECO:0000244|PDB:1TUZ}.
FT   HELIX        27     35       {ECO:0000244|PDB:1TUZ}.
FT   HELIX        38     42       {ECO:0000244|PDB:1TUZ}.
FT   HELIX        50     60       {ECO:0000244|PDB:1TUZ}.
FT   HELIX        68     77       {ECO:0000244|PDB:1TUZ}.
FT   HELIX        96    107       {ECO:0000244|PDB:1TUZ}.
SQ   SEQUENCE   735 AA;  82630 MW;  ACAA0AD186EE64A0 CRC64;
     MAKERGLISP SDFAQLQKYM EYSTKKVSDV LKLFEDGEMA KYVQGDAIGY EGFQQFLKIY
     LEVDNVPRHL SLALFQSFET GHCLNETNVT KDVVCLNDVS CYFSLLEGGR PEDKLEFTFK
     LYDTDRNGIL DSSEVDKIIL QMMRVAEYLD WDVSELRPIL QEMMKEIDYD GSGSVSQAEW
     VRAGATTVPL LVLLGLEMTL KDDGQHMWRP KRFPRPVYCN LCESSIGLGK QGLSCNLCKY
     TVHDQCAMKA LPCEVSTYAK SRKDIGVQSH VWVRGGCESG RCDRCQKKIR IYHSLTGLHC
     VWCHLEIHDD CLQAVGHECD CGLLRDHILP PSSIYPSVLA SGPDRKNSKT SQKTMDDLNL
     STSEALRIDP VPNTHPLLVF VNPKSGGKQG QRVLWKFQYI LNPRQVFNLL KDGPEIGLRL
     FKDVPDSRIL VCGGDGTVGW ILETIDKANL PVLPPVAVLP LGTGNDLARC LRWGGGYEGQ
     NLAKILKDLE MSKVVHMDRW SVEVIPQQTE EKSDPVPFQI INNYFSIGVD ASIAHRFHIM
     REKYPEKFNS RMKNKLWYFE FATSESIFST CKKLEESLTV EICGKPLDLS NLSLEGIAVL
     NIPSMHGGSN LWGDTRRPHG DIYGINQALG ATAKVITDPD ILKTCVPDLS DKRLEVVGLE
     GAIEMGQIYT KLKNAGRRLA KCSEITFHTT KTLPMQIDGE PWMQTPCTIK ITHKNQMPML
     MGPPPRSTNF FGFLS
//
